A recent study reported that intracerebral hemorrhage disrupts the blood–brain barrier (BBB) function via activation of IL-1β/RhoA/ROCK/NFκB signaling, which results from increased degradation of the inhibitor of κB (IκB) [55]. The gene discussed is IL1B; the disease is intracerebral hemorrhage.